ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    The Fibrinogen-Like Protein 2 Molecule Influences the Development of Thymic Regulatory T-Cells

    C. Lam1, S. Moshkelgosha1, G. A. Levy2, A. Chruscinski3, S. C. Juvet4

    1Latner Thoracic Surgery Research Laboratories, University Health Network, Toronto, ON, Canada, 2Multi Organ Transplant Program, University Health Network, Toronto, ON, Canada, 3Toronto General Hospital Research Institute (TGHRI), University Health Network, Toronto, ON, Canada, 4Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada

    *Purpose: Transplantation is the primary treatment for patients with end-stage organ failure. However, long-term outcomes are limited by immunosuppressant toxicities and chronic graft rejection. Identifying…
  • 2020 American Transplant Congress

    ABH Subtype-Specific Tolerance after ABO-Mismatched Hematopoietic Cell Transplantation

    B. Motyka1, A. Halpin1, J. Pearcey1, A. Kariminia2, A. Halevy2, S. Maier1, A. Halevy2, P. Subrt2, C. W. Cairo1, G. D. Cuvelier3, K. R. Schultz2, L. J. West1

    1Alberta Transplant Institute, University of Alberta, Edmonton, AB, Canada, 2British Columbia Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada, 3CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada

    *Purpose: ABO-mediated immunity is reported to have minimal detrimental impact after ABO-mismatched hematopoietic cell transplantation (HCT). Patients are generally presumed ‘tolerant’ with regard to ABO.…
  • 2020 American Transplant Congress

    A Bioinformatics Pipeline for the Identification of Crucial Factors for Transplant Rejection Based on NGS Data

    J. Vetter1, A. Heinzel2, C. Aschauer2, R. Reindl-Schwaighofer2, K. Jelencsics2, K. Hu2, R. Oberbauer2, S. Winkler1, S. Schaller1

    1Bioinformatics Research Group, University of Applied Sciences Upper Austria, Hagenberg Campus, Hagenberg im Muehlkreis, Austria, 2Department of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria

    *Purpose: T and B cells are crucial parts of the human immune system and play an important role in transplantation. Since the mechanisms leading to…
  • 2020 American Transplant Congress

    Circulating Exosomes with Cardiac Self-Antigens, Myosin and Vimentin, Induced Immune Responses Leading to Rejection Following Heterotopic Cardiac Transplantation Immunosuppressed with mTOR Inhibitor and Low Dose of IL-2 Therapy

    Y. Itabashi, R. Ravichandran, S. Bansal, T. Fleming, T. Mohanakumar

    Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

    *Purpose: The aim of the study is to determine the role for circulating exosomes with cardiac self-antigens (SAgs) (Myosin, Vimentin) in the development of immune…
  • 2020 American Transplant Congress

    Post-Transplantation Lymph Node Fibrosis: Significant Implications in Transplant Tolerance

    X. Li1, J. Zhao1, L. Jiang1, M. Uehara1, V. Kasinath1, S. Shin1, S. G. Tullius1, J. S. Bromberg2, R. Abdi1

    1Brigham and Women's Hospital, Boston, MA, 2University of Maryland School of Medicine, Boston, MA

    *Purpose: Lymph nodes (LNs) have been regarded as primary activation sites for alloimmunity following transplantation, but our group has revealed an additional dimension to their…
  • 2020 American Transplant Congress

    Withaferin A Prolongs Islet Allograft Survival in a Mouse Transplant Model by Preventing T Lymphocyte Proliferation and Dendritic Cell Maturation

    K. Kumano1, M. A. Kanak2, S. Vasu1, Y. Liu1, M. Lawrence1, B. Naziruddin1

    1Baylor University Medical Ctr, Dallas, TX, 2Virginial Commonwealth University Medical Center, Richmond, VA

    *Purpose: Chronic decline in islet graft function and toxicities imposed by immunosuppressant drugs remain as challenges to the widespread use of islet transplantation for type…
  • 2020 American Transplant Congress

    Prevalence of Risk Factors for NAFLD among Living Liver Donors

    D. A. Axelrod1, M. Simpson2, E. Pomfret3, A. Ehrlich4, S. Rwema4, R. Chung4, F. Gordon5

    1Surgery, University of Iowa, Iowa CIty, IA, 2Surgery, Lahey Clinic, Burlington, MA, 3University of Colorado, Denver, CA, 4Mass General Hospital, Boston, MA, 5Lahey, Burlington, MA

    *Purpose: The development of non-alcoholic fatty liver (NAFLD) disease has been strongly associated with the presence of polymorphisms in PNPLA3 rs738409. When compared with wild…
  • 2020 American Transplant Congress

    The Effect of Expanding Utilization of Living Donor Liver Transplantation tn the United States

    K. N. Wanis1, A. Sarvet1, M. J. Stensrud1, B. Al-Judaibi2, K. Tomiyama3, R. Hernandez-Alejandro3

    1Epidemiology, Harvard School of Public Health, Boston, MA, 2Division of Transplantation, University of Rochester, Rochester, NY, 3Division of Transplantation/Hepatobiliary Surgery, Department of Surgery, University of Rochester, Rochester, NY

    *Purpose: We estimated the effect that expansion of living donor liver transplantation (LDLT) would have on mortality for individuals added to the waitlist.*Methods: Using data…
  • 2020 American Transplant Congress

    Efficacy of Generic Sofosbuvir and Branded Daclatasvir Compared to Sofosbuvir and Ledipasvir Combination in the Treatment of Genotype 4 Hepatitis C Virus

    H. Joharji, D. Alkortas, A. Ajlan, E. Devol, M. Ahmed, F. Aba Al-Khail, H. Elsiesy, M. Alsebayel, H. Alashgar, M. Alquaiz, W. Alhamoudi, A. Almoshishir, A. Aljedai

    King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    *Purpose: Genotype 4 HCV is the most common genotype in Saudi Arabia and the Middle East. Management of HCV has shifted in the last few…
  • 2020 American Transplant Congress

    Incidence of Non-Tuberculous Mycobacteria in the Transplant Population at a University Transplant Center in Northern Florida

    D. Schain, Z. Breslow, G. El Helou, A. Cannella

    Medicine/IDGM, Univ of Florida, College of Med, Gainesville, FL

    *Purpose: Over the past decade, there has been an increase in the number of non-tuberculous mycobacteria (NTM) infections in the United States, especially in the…
  • « Previous Page
  • 1
  • …
  • 380
  • 381
  • 382
  • 383
  • 384
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences